Literature DB >> 32434536

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.

Ke Xu1, Dongkyoo Park1, Andrew T Magis2, Jun Zhang3, Wei Zhou4, Gabriel L Sica5, Suresh S Ramalingam4, Walter J Curran1, Xingming Deng6.   

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Entities:  

Year:  2020        PMID: 32434536      PMCID: PMC7238649          DOI: 10.1186/s12943-020-01214-5

Source DB:  PubMed          Journal:  Mol Cancer        ISSN: 1476-4598            Impact factor:   27.401


  1 in total

1.  Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.

Authors:  Ke Xu; Dongkyoo Park; Andrew T Magis; Jun Zhang; Wei Zhou; Gabriel L Sica; Suresh S Ramalingam; Walter J Curran; Xingming Deng
Journal:  Mol Cancer       Date:  2019-04-10       Impact factor: 27.401

  1 in total
  1 in total

1.  Thermal Shift Assay for Small GTPase Stability Screening: Evaluation and Suitability.

Authors:  Kari Kopra; Salla Valtonen; Randa Mahran; Jonas N Kapp; Nazia Hassan; William Gillette; Bryce Dennis; Lianbo Li; Kenneth D Westover; Andreas Plückthun; Harri Härmä
Journal:  Int J Mol Sci       Date:  2022-06-26       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.